Trial intelligence / Profile preview

NAC and Fenoldopam for Renal Protection in Cardiac Surgery

NCT00122018Phase 2Completed

Start
May 2002
Primary completion
Mar 2006
Modality
Classical Binding Small Molecules
01

Overview

A Phase 2 trial of acetylcysteine, fenoldopam in acute kidney injury (AKI). Started May 2002; status: completed.

02

Drugs

acetylcysteinefenoldopam
03

Conditions

acute kidney injury (AKI)

Beyond the preview

Go deeper on NCT00122018.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00122018.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call